Education
About Us
Working with TipRanks
Follow Us
Douglas J Swirsky Insider Profile
4 Followers
Douglas J Swirsky, Chief Financial Officer at MaxCyte, holds 111.81K shares in MaxCyte (Ticker: GB:MXCT). Most recently, Douglas J Swirsky Sold 6,939p shares of MaxCyte on Mar 20, 2025 for an estimated value of 22.06K.
Douglas J Swirsky MaxCyte (MXCT)Chief Financial Officer
MaxCyte (MXCT)
Chief Financial Officer
Not Ranked
Douglas J Swirsky has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Douglas J Swirsky does not currently own shares as a corporate insider.
A breakdown of Douglas J Swirsky's holdings
Insider Roles
Douglas J Swirsky does not currently hold a role as a corporate insider.
Roles that Douglas J Swirsky holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Douglas J Swirsky
Douglas J Swirsky's Trading History
List of latest transactions for each holding click on a transaction to see Douglas J Swirsky's performance on stock
You May Also Like
Douglas J Swirsky insider profile FAQ
What is the percentage of profitable transactions made by Douglas J Swirsky?
The percentage of profitable transactions made by Douglas J Swirsky is ―.
What is the average return per transaction made by Douglas J Swirsky?
The average return per transaction made by Douglas J Swirsky is ―.
What stocks does Douglas J Swirsky hold?
Douglas J Swirsky holds: GB:MXCT stocks.
What was Douglas J Swirsky’s latest transaction?
Douglas J Swirsky latest transaction was an Informative Sell of 22.06K.
What was Douglas J Swirsky's most profitable transaction?
Douglas J Swirsky’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Douglas J Swirsky's role in MaxCyte?
Douglas J Swirsky's role in MaxCyte is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.